Kindred Healthcare (NYSE:KND) Rating Increased to Hold at Zacks Investment Research

Kindred Healthcare (NYSE:KND) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Tuesday, November 21st.

According to Zacks, “Kindred Healthcare, Inc. is one of the largest providers of long-term healthcare services in the United States. Their health services division provides long-term care services by operating nursing centers and a rehabilitation therapy business, and their hospital division provides long-term acute care services by operating hospitals and an institutional pharmacy business. “

Other analysts have also recently issued research reports about the stock. Stifel Nicolaus raised shares of Kindred Healthcare from a “sell” rating to a “hold” rating and set a $7.00 target price on the stock in a research note on Monday, November 20th. Deutsche Bank reiterated a “hold” rating and set a $9.00 price target (down previously from $10.00) on shares of Kindred Healthcare in a report on Monday, September 18th. BidaskClub lowered shares of Kindred Healthcare from a “sell” rating to a “strong sell” rating in a report on Tuesday, August 8th. Mizuho reiterated a “neutral” rating and set a $7.50 price target (down previously from $8.00) on shares of Kindred Healthcare in a report on Tuesday, October 10th. Finally, ValuEngine upgraded shares of Kindred Healthcare from a “sell” rating to a “hold” rating in a report on Thursday, November 9th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $8.86.

Shares of Kindred Healthcare (KND) traded down $0.05 during trading hours on Tuesday, reaching $7.15. 841,953 shares of the company were exchanged, compared to its average volume of 1,189,727. The company has a market capitalization of $634.61, a PE ratio of 36.50, a price-to-earnings-growth ratio of 3.61 and a beta of 1.21. The company has a debt-to-equity ratio of 6.22, a current ratio of 1.55 and a quick ratio of 1.53. Kindred Healthcare has a fifty-two week low of $5.50 and a fifty-two week high of $11.90.

Kindred Healthcare (NYSE:KND) last posted its earnings results on Monday, November 6th. The health services provider reported ($0.11) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.08. The firm had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.44 billion. Kindred Healthcare had a negative net margin of 8.06% and a positive return on equity of 2.29%. The company’s revenue was down 5.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.05 earnings per share. sell-side analysts predict that Kindred Healthcare will post 0.27 EPS for the current fiscal year.

Several large investors have recently bought and sold shares of KND. Janus Henderson Group PLC bought a new stake in shares of Kindred Healthcare during the second quarter worth about $130,000. Paloma Partners Management Co bought a new stake in shares of Kindred Healthcare during the first quarter worth about $133,000. Highbridge Capital Management LLC bought a new stake in shares of Kindred Healthcare during the third quarter worth about $133,000. Amalgamated Bank increased its position in shares of Kindred Healthcare by 0.9% during the second quarter. Amalgamated Bank now owns 11,518 shares of the health services provider’s stock worth $134,000 after acquiring an additional 108 shares in the last quarter. Finally, State of Alaska Department of Revenue increased its position in shares of Kindred Healthcare by 80.0% during the second quarter. State of Alaska Department of Revenue now owns 16,916 shares of the health services provider’s stock worth $197,000 after acquiring an additional 7,516 shares in the last quarter. 89.65% of the stock is owned by institutional investors.

TRADEMARK VIOLATION NOTICE: “Kindred Healthcare (NYSE:KND) Rating Increased to Hold at Zacks Investment Research” was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international copyright and trademark laws. The correct version of this report can be viewed at https://ledgergazette.com/2017/12/07/kindred-healthcare-inc-knd-upgraded-by-zacks-investment-research-to-hold.html.

About Kindred Healthcare

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Get a free copy of the Zacks research report on Kindred Healthcare (KND)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply